Purchase Order HHSN272201700118P

This firm fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Genscript USA Inc., a for-profit biotechnology company, for the development of murine hybridoma and V region sequencing. The contract has a potential value of $174,903.00 and a completion date of July 14, 2021. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services, which it has...

This firm fixed price purchase order was awarded by the National Institutes of Health National Cancer Institute to Genscript USA Inc. for $30,280. The contract is for the acquisition of recombinant antibody against mouse ErbB2 (HER2) domain IV via custom protein production services. Specifically, Genscript will immunize rabbits with the antigen protein, collect B cell clones to screen for binding to mouse HER2, collect supernatants from 20 antibody clones, and produce and purify the...

The U.S. Food and Drug Administration (FDA) awarded an $272.4K firm fixed-price purchase order to Antibody Solutions for the production of monoclonal antibodies production clones. The contract, designated as a Total Small Business set-aside, was awarded on August 1, 2024, with an ultimate completion date of July 31, 2029. Performance will take place at the contractor's facility in Santa Clara, California. This procurement supports the FDA's regulatory and scientific mission, as monoclonal...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $3,799.00 firm-fixed-price purchase order contract to Lakepharma, Inc., a minority-owned, for-profit, Asian-Pacific American-owned business, for the cloning and sequencing of mouse hybridoma. The contract has a completion date of September 29, 2017 and was awarded on August 2, 2017. Lakepharma, Inc. is a Contract Development and Manufacturing Organization...

The National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $59,541 firm fixed price purchase order to Genscript USA Inc. to provide customized antibody synthesis, expression, purification, and plasmid preparations in support of the Laboratory of Malaria Immunology and Vaccinology's (LMIV) malaria vaccine research. Per the original solicitation, LMIV requires custom monoclonal antibodies that can label and sort immune cell subsets in its colony...

The U.S. government awarded a purchase order valued at $5,075.85 to Genscript USA Inc., a biotechnology company headquartered in Piscataway, New Jersey, for monoclonal antibody products. The contract, awarded on September 19, 2016, with an ultimate completion date of March 20, 2017, was issued under a firm fixed-price pricing structure by a civilian federal agency (Southeast Area). No set-aside designation was applied to this award. The place of performance is located in Piscataway, New...

This federal contract award, valued at $3,869.87, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the procurement of mouse antibodies, which are likely to support various biomedical research and public health initiatives at NIAID and other agencies within the Department of Health and Human Services (HHS)....

Genscript USA Inc. was awarded a $54,900 firm-fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide customized antibody and plasmid preparation services. The award is associated with a pre-solicitation notice indicating the NIAID's intent to negotiate on a sole-source basis with Genscript for 100 customized antibodies and 200 plasmid preparations to support identification of...

This is a firm fixed-price purchase order awarded by the Midwest Area of the U.S. Department of Agriculture to Envigo Bioproducts Inc., a discovery and development contract research organization (CRO). The $4,425 contract is for the sub-cloning of an existing hybridoma cell line. Envigo Bioproducts Inc. has provided similar specialized services, including hybridoma production, antibody production, and cell line storage and sub-cloning, to the USDA Agricultural Research Service under past prime...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $33,560 purchase order to Antibodies Incorporated for two monoclonal antibody projects. Antibodies Incorporated, doing business as Antibodies Inc., will deliver the requested monoclonal antibodies from its Bethesda, Maryland facility within the one-month period of performance ending September 30, 2023. As the prime contractor, Antibodies Inc. will be responsible for completion of the two...